-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Reiterates Buy on Bioage Labs, Maintains $40 Price Target

Benzinga·08/03/2026 09:25:09
語音播報
BTIG analyst Thomas Shrader reiterates Bioage Labs (NASDAQ:BIOA) with a Buy and maintains $40 price target.